Retroperitoneal Sarcomas

Andrea S Porpiglia; Sanjay S Reddy; Jeffrey M Farma

doi:10.1016/j.suc.2016.05.009

Retroperitoneal Sarcomas

Surg Clin North Am. 2016 Oct;96(5):993-1001. doi: 10.1016/j.suc.2016.05.009.

Authors

Andrea S Porpiglia¹, Sanjay S Reddy², Jeffrey M Farma³

Affiliations

¹ Crozer Keystone Health Network, Department of Surgery, 2100 Keystone Ave, Drexell Hill, PA 19026, USA.
² Fox Chase Cancer Center, Department of Surgery, 333 Cottman Ave, Philadelphia, PA 19111, USA.
³ Fox Chase Cancer Center, Department of Surgery, 333 Cottman Ave, Philadelphia, PA 19111, USA. Electronic address: jeffrey.farma@fccc.edu.

PMID: 27542638
DOI: 10.1016/j.suc.2016.05.009

Abstract

Retroperitoneal sarcomas are rare tumors, representing only 15% of all sarcomas. The mainstay of therapy is surgical resection with negative margins. However, this is challenging because of the late presentation of many of these tumors and involvement with adjacent structures. Decisions on radiation therapy and chemotherapy should be made in a multidisciplinary setting at a tertiary referral center.

Keywords: Chemotherapy; Radiation; Retroperitoneal liposarcoma; Retroperitoneal sarcoma; Surgery.

Publication types

Review

MeSH terms

Chemoradiotherapy / methods
Humans
Retroperitoneal Neoplasms / therapy*
Sarcoma / therapy*